Case studies showing clinical signs and management of cutaneous toxicity of the MEK1/2 inhibitor AZD6244 (ARRY-142886) in patients with solid tumours.

Authors
Publication date
1 January 2010
Publisher

Abstract

Item does not contain fulltex

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Radboud Repository

    redirect
    oaioai:repository.ubn.ru.nl:2066/...
    Last time updated on 06/09/2013